Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.
By
Samantha Rossi
• April 23, 2024
Share this:
Related Episodes
Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.
By
Sarah Jarvis
•
September 11, 2025
Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC
By
Samantha Rossi
•
September 2, 2025
Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.
By
Sarah Jarvis
•
August 28, 2025
Samantha Rossi
Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.
Related Posts
Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.
Last chance to register for virtual phlebotomy workshop
Join us on Oct. 29 for a SAAmplify-αSYN testing webinar
